Institute for Human Immunology and Protein Therapeutics
Institute for Human Immunology and Protein Therapeutics
  • Home
  • About
  • People
    • Dr. George Georgiou
    • Current Members
    • Alumni
  • Publications
  • Recent Highlights
  • Contact
  • Lab Resources
  • Search

Anthrax Treatment Engineered by Texas CHE Researchers Gains FDA Approval

April 4, 2016/in News /by admin

Researchers at The University of Texas at Austin, including Texas ChE’s Dr. George Georgiou and Dr. Jennifer Maynard, successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA). Part of the molecule was engineered at UT Austin before being licensed to New Jersey-based pharmaceutical company Elusys Therapeutics for further development. It will be sold under the name Anthim.

https://che.utexas.edu/2016/04/04/anthrax-treatment-engineered-texas-che-researchers-gains-fda-approval/

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

Recent Posts

  • Our Covid Research Featured on NIH Director’s Blog
  • The Institute a Member of the Nationwide NIH COVID-19 SeroNet
  • Drs. Ippolito and Lavinder featured in the Austin American Statesman
  • Institute Develops Antibody Test for COVID-19 That is Sensitive, Specific and Scalable
  • The Institute contributes to COVID-19 vaccine development

Recent Comments

    Archives

    • May 2021
    • October 2020
    • September 2020
    • August 2020
    • June 2020
    • February 2020
    • September 2019
    • August 2018
    • March 2018
    • November 2017
    • September 2017
    • April 2017
    • February 2017
    • December 2016
    • October 2016
    • August 2016
    • July 2016
    • April 2016
    • March 2016
    • December 2015
    • March 2014

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Popular
    • George Georgiou, 2014 UT Austin Inventor of the YearMarch 31, 2014 - 12:44 AM
    • Dr. Georgiou Elected to the National Academy of Invento...December 15, 2015 - 12:45 AM
    • Fighting Lymphoma Cancer with Genomics and Supercomputi...March 31, 2016 - 12:45 AM
    • Anthrax Treatment Engineered by Texas CHE Researchers Gains...April 4, 2016 - 12:47 AM
    Recent
    • Our Covid Research Featured on NIH Director’s Blo...May 18, 2021 - 4:40 PM
    • The Institute a Member of the Nationwide NIH COVID-19 S...October 8, 2020 - 11:25 PM
    • Drs. Ippolito and Lavinder featured in the Austin American...September 23, 2020 - 2:17 PM
    • Institute Develops Antibody Test for COVID-19 That is Sensitive,...September 13, 2020 - 4:19 PM
    Comments
    Tags
    © Copyright - Institute for Human Immunology and Protein Therapeutics - powered by Enfold WordPress Theme
    Fighting Lymphoma Cancer with Genomics and Supercomputing UT-Austin Researchers Focus on Poliovirus and The Human Immune Response
    Scroll to top